Integer Holdings, Astrana Health, Surgery Partners, IQVIA, and Supernus Pharmaceuticals Shares Skyrocket, What You Need To Know

What Happened?

A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested that with inflation risks moderating and unemployment remaining low, the Federal Reserve might consider a shift in its monetary policy stance, including potential interest rate cuts. This outlook eased market concerns about prolonged high interest rates and their impact on economic growth. The prospect of lower borrowing costs bolstered investor confidence, particularly in sectors that have lagged, leading to a broad rally across the market.

The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks.

Among others, the following stocks were impacted:

Medical Devices & Supplies - Specialty company Integer Holdings (NYSE:ITGR) jumped 3.4%. Is now the time to buy Integer Holdings? Access our full analysis report here, it’s free. Healthcare Technology for Providers company Astrana Health (NASDAQ:ASTH) jumped 3.1%. Is now the time to buy Astrana Health? Access our full analysis report here, it’s free. Outpatient & Specialty Care company Surgery Partners (NASDAQ:SGRY) jumped 3.1%. Is now the time to buy Surgery Partners? Access our full analysis report here, it’s free. Drug Development Inputs & Services company IQVIA (NYSE:IQV) jumped 3.5%. Is now the time to buy IQVIA? Access our full analysis report here, it’s free. Branded Pharmaceuticals company Supernus Pharmaceuticals (NASDAQ:SUPN) jumped 3.3%. Is now the time to buy Supernus Pharmaceuticals? Access our full analysis report here, it’s free.

Zooming In On IQVIA (IQV)

IQVIA’s shares are not very volatile and have only had 9 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business.

The previous big move we wrote about was 1 day ago when the stock dropped 3% on the news that markets continued to decline, as investors grew cautious ahead of a key speech by Federal Reserve Chair Jerome Powell. The move came as U.S. equity markets recorded a fifth consecutive day of losses for major indexes like the S&P 500, with technology stocks experiencing the largest declines. Investors have grown wary that the sharp rally in the tech sector since April may have advanced too far. The market-wide caution is largely driven by the upcoming Jackson Hole symposium, a meeting of central bankers, where traders are anxiously awaiting Fed Chair Powell's speech on Friday for guidance on the future path of interest rates.

Story Continues

IQVIA is down 2% since the beginning of the year, and at $191.19 per share, it is trading 24% below its 52-week high of $251.55 from August 2024. Investors who bought $1,000 worth of IQVIA’s shares 5 years ago would now be looking at an investment worth $1,224.

Today’s young investors likely haven’t read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.

View Comments